和相关实体的MiT家族转位癌症
1Departments of Pathology and Oncology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Histopathology
|December 12, 2025
概括
MiT家族转位细胞癌 (RCC) 涉及TFE3和TFEB转录因子. 由于重叠的功能,这些瘤具有相似之处,导致它们被分组并有助于差异诊断.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 包括TFE3和TFEB在内的转录因子MiT家族与特定的细胞癌 (RCC) 亚型有关.
- 涉及TFE3和TFEB的基因融合具有独特的RCC的特征,例如Xp11转位RCC和t(6;11)转位RCC.
- 这些RCC亚型由于TFE3和TFEB的重叠功能,表现出形态相似性和共享下游目标.
研究的目的:
- 审查有关MiT家族转位RCCs的当前知识.
- 讨论与TFE3和TFEB发生变化的相关瘤,包括TFE3重组的PEComa和TFEB放大的RCC.
- 概述这些分子定义的瘤的差异诊断考虑.
主要方法:
- 关于分子定义瘤的文献综述.
- 分析涉及MiT家族转录因子的基因融合和放大.
- 对RCC亚型的形态和分子特征进行比较分析.
主要成果:
- TFE3和TFEB基因融合定义了具有重叠特征的特定RCC亚型.
- MiT家族转位RCC,TFE3重新排列的PEComa和TFEB增强的RCC代表了一系列相关的瘤.
- 了解这些分子变化对于准确诊断至关重要.
结论:
- 米特家族转位RCC是一种独特的新生瘤群,其特征是TFE3或TFEB变异.
- 相关实体如TFE3-PEComas和TFEB放大RCC扩大了MiT家族驱动的瘤的范围.
- 准确的诊断依赖于将分子发现与临床病理学特征相结合.
相关概念视频
01:28Kidney Transplant I: Introduction
307
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...
307
01:26Kidney Transplant II: Surgical Procedure
279
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
279
02:30Metastasis
6.3K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.3K